Rcra Waste No. P043
Rcra Waste No. P043 Brand names, Rcra Waste No. P043 Analogs
- DFP
- Diflupyl
- Diflurophate
- Diisopropoxyphosphoryl Fluoride
- Diisopropyl Cyanomethylphosphonate,
- Diisopropyl Fluoridophosphate
- Diisopropyl Fluorophosphate
- Diisopropyl Fluorophosphonate
- Diisopropyl Phosphofluoridate
- Diisopropyl Phosphorofluoridate
- Diisopropylfluorfosfat
- Diisopropylfluorfosfat [Czech]
- Diisopropylfluorophosphoric Acid Ester
- Diisopropylfluorphosphorsaeureester
- Disiopropyl Fluorophosphonate
- Dyflos
- Floropryl
- Fluorodiisopropyl Phosphate
- Fluoropryl
- Fluostigmine
- Fluropryl
- Humorsol
- Isofluorophate
- Isofluorphate
- Isoflurophosphate
- Isopropyl Fluophosphate
- Isopropyl Phosphorofluoridate
- Neoglaucit
- O,O-Diisopropyl Fluorophosphate
- PF-3
- Phospholine Iodide
- Rcra Waste No. P043
- Rcra Waste Number P043
Rcra Waste No. P043 Brand Names Mixture
- No information avaliable
Rcra Waste No. P043 Chemical_Formula
C6H14FO3P
Rcra Waste No. P043 RX_link
No information avaliable
Rcra Waste No. P043 fda sheet
Rcra Waste No. P043 msds (material safety sheet)
Rcra Waste No. P043 Synthesis Reference
No information avaliable
Rcra Waste No. P043 Molecular Weight
184.146 g/mol
Rcra Waste No. P043 Melting Point
-82 oC
Rcra Waste No. P043 H2O Solubility
1.54E+004 mg/L
Rcra Waste No. P043 State
Liquid
Rcra Waste No. P043 LogP
1.13
Rcra Waste No. P043 Dosage Forms
No information avaliable
Rcra Waste No. P043 Indication
For use in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia.
Rcra Waste No. P043 Pharmacology
Isoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme.
Rcra Waste No. P043 Absorption
No information avaliable
Rcra Waste No. P043 side effects and Toxicity
Signs of overdose include increased sweating, loss of bladder control, muscle weakness, nausea, vomiting, diarrhea, or stomach cramps or pain, shortness of breath, tightness in chest, or wheezing, slow or irregular heartbeat, unusual tiredness or weakness, watering of mouth.
Rcra Waste No. P043 Patient Information
No information avaliable
Rcra Waste No. P043 Organisms Affected
Humans and other mammals
